Internal Medicine

3151 questions

Question 401Question →

A 6464-year-old man is brought to the emergency department by his family due to severe shortness of breath, generalized weakness, and newly developed confusion over the past 1212 hours. He has a history of severe chronic obstructive pulmonary disease (COPD) and type 2 diabetes mellitus. For the past three days, he has had a worsening cough productive of thick, yellow sputum and a fever. His temperature is 38.8∘C38.8^\circ\text{C} (101.8∘F101.8^\circ\text{F}), blood pressure is 88/54 mmHg88/54\text{ mmHg}, pulse is 122/min122/\text{min}, and respirations are 34/min34/\text{min}. On physical examination, the patient is lethargic and oriented only to person. He is using accessory muscles of respiration. Lung auscultation demonstrates diffuse rhonchi bilaterally and localized crackles in the right lower lung field. Jugular venous pressure is 6 cm H2O6\text{ cm H}_2\text{O}. Heart sounds are normal with no murmurs or gallops. There is no lower extremity edema. A chest radiograph reveals a right lower lobe consolidation. Arterial blood gas analysis on room air shows:

pH: 7.247.24
pCO2\text{pCO}_2: 35 mmHg35\text{ mmHg}
pO2\text{pO}_2: 58 mmHg58\text{ mmHg}
HCO3−\text{HCO}_3^-: 15 mEq/L15\text{ mEq/L}

Serum lactate is 5.4 mmol/L5.4\text{ mmol/L}. The patient receives a 30 mL/kg30\text{ mL/kg} intravenous fluid bolus, and empiric intravenous ceftriaxone and azithromycin are initiated. What is the most appropriate next step in management?

Show answer & explanation

Answer: Endotracheal intubation and mechanical ventilation

Answer

Endotracheal intubation and mechanical ventilation
The correct answer is endotracheal intubation and mechanical ventilation. This patient presents with septic shock secondary to community-acquired pneumonia, complicated by impending respiratory failure. The arterial blood gas demonstrates a primary metabolic acidosis (pH 7.247.24, HCO3−\text{HCO}_3^- 15 mEq/L15\text{ mEq/L}), driven by lactic acidosis from tissue hypoperfusion. According to Winter's formula (1.5×HCO3−+8±21.5 \times \text{HCO}_3^- + 8 \pm 2), his expected pCO2\text{pCO}_2 should be between 28.528.5 and 32.5 mmHg32.5\text{ mmHg}. His actual pCO2\text{pCO}_2 of 35 mmHg35\text{ mmHg} is inappropriately high, indicating a concurrent respiratory acidosis. Despite a respiratory rate of 34/min34/\text{min}, his underlying COPD and respiratory muscle fatigue prevent him from adequately ventilating. Given his concurrent respiratory acidosis, hemodynamic instability, and altered mental status (which strictly contraindicates noninvasive ventilation), he requires immediate endotracheal intubation to secure the airway and provide ventilatory support.

Step-by-Step Solution

1
Identify the primary acid-base disturbance from the arterial blood gas.
The pH is 7.247.24 (acidemia) and HCO3−\text{HCO}_3^- is 15 mEq/L15\text{ mEq/L} (low). This indicates a primary metabolic acidosis, consistent with his elevated lactate (5.4 mmol/L5.4\text{ mmol/L}) due to septic shock.
Establishing the primary disorder is required to calculate the expected compensatory response.
2
Calculate the expected respiratory compensation using Winter's formula.
Expected pCO2=(1.5×HCO3−)+8±2=(1.5×15)+8±2=22.5+8±2=30.5±2\text{pCO}_2 = (1.5 \times \text{HCO}_3^-) + 8 \pm 2 = (1.5 \times 15) + 8 \pm 2 = 22.5 + 8 \pm 2 = 30.5 \pm 2. The expected pCO2\text{pCO}_2 range is 28.528.5 to 32.5 mmHg32.5\text{ mmHg}.
This determines if the patient's respiratory system is adequately compensating for the metabolic acidosis.
3
Compare the actual pCO2\text{pCO}_2 to the expected pCO2\text{pCO}_2.
The patient's actual pCO2\text{pCO}_2 (35 mmHg35\text{ mmHg}) is higher than the expected range (28.5−32.5 mmHg28.5 - 32.5\text{ mmHg}).
An actual pCO2\text{pCO}_2 higher than expected reveals a concurrent respiratory acidosis. Despite tachypnea (respirations 34/min34/\text{min}), the patient is fatiguing and unable to provide adequate alveolar ventilation.
4
Assess clinical status and determine the appropriate intervention.
The patient has impending respiratory failure (mixed acidosis), altered mental status (lethargy/confusion), and hemodynamic instability.
Altered mental status is a strict contraindication for noninvasive positive pressure ventilation. Therefore, definitive airway control via endotracheal intubation is required.

Key Concept

Patients with severe metabolic acidosis require profound hyperventilation to compensate. An inappropriately 'normal' or elevated pCO2 in this setting indicates impending respiratory muscle fatigue and ventilatory failure, requiring immediate intubation, especially when accompanied by altered mental status.
Question 402Question →

A 7171-year-old man is brought to the emergency department due to progressively worsening shortness of breath and an increased volume of thick, purulent sputum over the past 4848 hours. His medical history is significant for severe chronic obstructive pulmonary disease (COPD), ischemic heart disease, and stage 3 chronic kidney disease. Vital signs show a temperature of 37.6∘C37.6^\circ\text{C} (99.7∘F99.7^\circ\text{F}), heart rate of 112112/min, respiratory rate of 2626/min, and blood pressure of 155/88155/88 mm Hg. Oxygen saturation is 86%86\% on room air.

On physical examination, the patient appears somnolent but arouses to verbal stimuli. Jugular venous pressure is estimated at 77 cm H 2_2 O. Chest auscultation reveals a markedly prolonged expiratory phase with diffuse bilateral wheezes and coarse rhonchi. No S3 gallop is appreciated. Bilateral 1+ pitting edema is present in the lower extremities.

An arterial blood gas analysis on room air reveals:

Laboratory TestResult
pH7.287.28
PaCO2_27272 mm Hg
PaO2_25252 mm Hg
HCO3−_3^-3232 mEq/L

A chest radiograph shows hyperlucent lung fields and flattened hemidiaphragms without focal consolidations or pleural effusions. A sputum Gram stain shows abundant polymorphonuclear leukocytes and Gram-negative coccobacilli.

Based on the clinical presentation and laboratory findings, which of the following are appropriate initial management steps for this patient? (Select all that apply)

Select all that apply

Show answer & explanation

Answer: Initiate noninvasive positive-pressure ventilation (NIPPV); Prescribe a short course of oral systemic glucocorticoids

Answer

The correct management steps are to initiate noninvasive positive-pressure ventilation (NIPPV) and to prescribe a short course of oral systemic glucocorticoids.
This patient is experiencing a severe acute exacerbation of COPD, complicated by acute-on-chronic hypercapnic respiratory failure (indicated by a pH of 7.287.28, PaCO 2_2 of 7272 mm Hg, and elevated baseline bicarbonate) along with mild CO 2_2 narcosis (somnolence). The standard of care for COPD patients presenting with a pH <7.35< 7.35 and PaCO 2_2 >45> 45 mm Hg is the prompt initiation of noninvasive positive-pressure ventilation (NIPPV). NIPPV improves alveolar ventilation, reduces the work of breathing, and has been proven to decrease both mortality and the need for endotracheal intubation. Concurrently, systemic glucocorticoids (such as oral prednisone or intravenous methylprednisolone) are indicated in all severe COPD exacerbations to rapidly reduce airway inflammation, improve forced expiratory volume, and shorten recovery time.

Step-by-Step Solution

1
Analyze the patient's clinical presentation and acid-base status.
The patient is experiencing an acute exacerbation of COPD with acute-on-chronic hypercapnic respiratory failure, indicated by a pH of 7.28, PaCO2 of 72 mm Hg, and mild encephalopathy (somnolence).
Accurately identifying the primary physiological derangement and its severity dictates the urgency and modality of respiratory support.
2
Determine the most appropriate respiratory intervention.
NIPPV is strongly indicated as the first-line respiratory support.
NIPPV is the standard of care for COPD exacerbations complicated by respiratory acidosis (pH < 7.35 and PaCO2 > 45 mm Hg), significantly reducing mortality and the need for invasive endotracheal intubation.
3
Select the appropriate pharmacologic therapies for a severe COPD exacerbation.
Systemic glucocorticoids and targeted antibiotics should be administered.
Glucocorticoids reduce airway inflammation and accelerate clinical recovery. Antibiotics are indicated due to the presence of all three cardinal symptoms (increased dyspnea, sputum volume, and sputum purulence), but should target typical community-acquired organisms rather than utilizing empiric broad-spectrum coverage.

Key Concept

Management of acute exacerbations of COPD complicated by acute-on-chronic hypercapnic respiratory failure.
Question 403Question →

A 1919-year-old university student is evaluated in the emergency department for severe generalized weakness, abdominal cramping, and frequent vomiting over the past 2424 hours. She has a known history of type 1 diabetes mellitus and reports that her insulin pump malfunctioned yesterday. Vital signs show a temperature of 37.1∘37.1^\circ C (98.8∘98.8^\circ F), blood pressure of 105/65105/65 mm Hg, pulse of 115115/min, and respiratory rate of 2828/min with deep, sighing breaths.

Laboratory results are as follows:

TestResult
Sodium138138 mEq/L
Potassium5.15.1 mEq/L
Chloride103103 mEq/L
Bicarbonate1010 mEq/L

An arterial blood gas analysis on room air reveals:

ParameterResult
pH7.227.22
PaCO2_22323 mm Hg
PaO2_29898 mm Hg

Which of the following best characterizes this patient's current acid-base status?

Show answer & explanation

Answer: Primary metabolic acidosis with appropriate respiratory compensation

Answer

The patient has a primary metabolic acidosis with appropriate respiratory compensation.
The correct answer identifies that the patient has a primary metabolic acidosis (due to a pH of 7.22 and a low bicarbonate of 10 mEq/L) and that the respiratory compensation is fully appropriate. According to Winter's formula (1.5 × 10 + 8 = 23), the expected PaCO2 is exactly 23 mm Hg. Because the measured PaCO2 matches the expected value, no additional acid-base disorder is present.

Step-by-Step Solution

1
Determine the primary acid-base disturbance based on the pH.
The patient's pH is 7.227.22, which is less than the normal range (7.35−7.457.35 - 7.45), indicating an acidemia. The primary disorder driving this must be an acidosis.
The direction of the pH deviation firmly identifies whether the primary process is an acidosis or alkalosis.
2
Identify the primary driver of the acidemia using the PaCO2 and bicarbonate levels.
The bicarbonate level is low (1010 mEq/L), which would cause an acidemia. The PaCO 2_2 is also low (2323 mm Hg), which would typically cause an alkalemia. Therefore, the low bicarbonate is the primary pathological driver.
Matching the direction of the pH change to the corresponding metabolic or respiratory parameter identifies the primary disorder as a metabolic acidosis.
3
Calculate the expected respiratory compensation using Winter's formula.
Expected PaCO 2=(1.5×[HCO3−])+8±2_2 = (1.5 \times [\text{HCO}_3^-]) + 8 \pm 2. Plugging in the values: (1.5×10)+8=15+8=23±2(1.5 \times 10) + 8 = 15 + 8 = 23 \pm 2 mm Hg. The expected range is 2121 to 2525 mm Hg.
Winter's formula determines if the respiratory response (hyperventilation/Kussmaul respirations) to a metabolic acidosis is fully appropriate, or if there is a concurrent respiratory disorder.
4
Compare the expected PaCO2 to the measured PaCO2.
The measured PaCO 2_2 is 2323 mm Hg, which falls perfectly within the calculated expected range of 21−2521 - 25 mm Hg.
Because the measured PaCO 2_2 matches the expected compensation perfectly, the patient does not have a superimposed primary respiratory acidosis or alkalosis.

Key Concept

In patients presenting with a primary metabolic acidosis, the appropriate physiological respiratory compensation can be calculated using Winter's formula: Expected PaCO2 = (1.5 × [HCO3-]) + 8 ± 2. If the measured PaCO2 matches this expected value, the respiratory compensation is appropriate and there is no concurrent primary respiratory disorder.
Estimated Time:1m 0s
Question 404Question →

A 6565-year-old man is evaluated in the intensive care unit for worsening altered mental status and respiratory distress. He was admitted 22 days ago for community-acquired pneumonia and was started on appropriate intravenous antibiotics. His medical history includes chronic obstructive pulmonary disease (COPD) and hypertension. Temperature is 38.6∘C38.6^\circ\text{C} (101.5∘F101.5^\circ\text{F}), blood pressure is 88/54 mmHg88/54\text{ mmHg}, pulse is 112/min112/\text{min}, and respirations are 28/min28/\text{min}. Pulse oximetry shows 92%92\% on a 50%50\% Venturi mask. Physical examination reveals bilateral crackles and scattered wheezes. Laboratory results are as follows:

ParameterValue
Sodium142 mEq/L142\text{ mEq/L}
Potassium4.5 mEq/L4.5\text{ mEq/L}
Chloride104 mEq/L104\text{ mEq/L}
Bicarbonate14 mEq/L14\text{ mEq/L}
Blood urea nitrogen32 mg/dL32\text{ mg/dL}
Creatinine1.8 mg/dL1.8\text{ mg/dL}
Lactate4.2 mmol/L4.2\text{ mmol/L}

Arterial blood gas analysis on 50%50\% oxygen:

ParameterValue
pH7.227.22
PaCO2\text{PaCO}_235 mmHg35\text{ mmHg}
PaO2\text{PaO}_264 mmHg64\text{ mmHg}

Which of the following best characterizes this patient's current acid-base status?

Show answer & explanation

Answer: High anion gap metabolic acidosis and concurrent respiratory acidosis

Answer

High anion gap metabolic acidosis and concurrent respiratory acidosis
This patient has a mixed acid-base disorder consisting of a high anion gap metabolic acidosis and a concurrent respiratory acidosis. The acidemia (pH 7.227.22) is driven by a low bicarbonate (14 mEq/L14\text{ mEq/L}), indicating a primary metabolic acidosis. The anion gap is elevated at 24 mEq/L24\text{ mEq/L} (142−[104+14]142 - [104 + 14]), consistent with lactic acidosis secondary to septic shock from his severe pneumonia. To determine if respiratory compensation is adequate, Winter's formula must be applied: Expected PaCO2=(1.5×14)+8=29±2 mmHg\text{Expected PaCO}_2 = (1.5 \times 14) + 8 = 29 \pm 2\text{ mmHg}. Because the patient's measured PaCO2\text{PaCO}_2 (35 mmHg35\text{ mmHg}) is significantly higher than the expected maximal compensatory value of 31 mmHg31\text{ mmHg}, he has a concurrent respiratory acidosis. This indicates that his respiratory drive or mechanics (compromised by COPD and pneumonia) are failing to adequately clear CO2, signaling impending respiratory failure.

Step-by-Step Solution

1
Analyze the pH to determine the primary disorder.
The pH is 7.227.22, indicating acidemia.
Establishing acidemia or alkalemia is the first step in diagnosing an acid-base disorder.
2
Assess the primary driver of the acidemia.
The serum bicarbonate is low (14 mEq/L14\text{ mEq/L}), confirming a primary metabolic acidosis.
A low pH driven by a low bicarbonate defines metabolic acidosis.
3
Calculate the anion gap to classify the metabolic acidosis.
Anion Gap=Na+−(Cl−+HCO3−)=142−(104+14)=24 mEq/L\text{Anion Gap} = \text{Na}^+ - (\text{Cl}^- + \text{HCO}_3^-) = 142 - (104 + 14) = 24\text{ mEq/L}.
An elevated anion gap (>12 mEq/L> 12\text{ mEq/L}) confirms a high anion gap metabolic acidosis, consistent with this patient's elevated lactate from septic shock.
4
Calculate the expected respiratory compensation using Winter's formula.
Expected PaCO2=(1.5×HCO3−)+8±2=(1.5×14)+8±2=29±2 mmHg\text{Expected PaCO}_2 = (1.5 \times \text{HCO}_3^-) + 8 \pm 2 = (1.5 \times 14) + 8 \pm 2 = 29 \pm 2\text{ mmHg} (Range: 2727-31 mmHg31\text{ mmHg}).
This determines if the lungs are adequately blowing off CO2 to compensate for the metabolic acidosis.
5
Compare the measured PaCO2 to the expected PaCO2.
The measured PaCO2\text{PaCO}_2 (35 mmHg35\text{ mmHg}) is greater than the expected range (2727-31 mmHg31\text{ mmHg}).
A PaCO2 higher than expected indicates inadequate ventilation (concurrent respiratory acidosis), which is a sign of impending respiratory failure in a patient with COPD.

Key Concept

In patients with metabolic acidosis, Winter's formula must be used to calculate expected respiratory compensation; a measured PaCO2 higher than the expected range indicates a concurrent respiratory acidosis.
Estimated Time:1m 30s
Question 405Question →

A 6464-year-old man is admitted to the hospital with a 22-week history of progressively worsening mid-back pain and low-grade fevers. He has a history of poorly controlled type 2 diabetes mellitus. His temperature is 38.2∘C38.2^\circ\text{C} (100.8∘F100.8^\circ\text{F}), blood pressure is 128/78 mmHg128/78\text{ mmHg}, and pulse is 92/min92\text{/min}. Physical examination reveals point tenderness over the T10−T11T10-T11 spinous processes. Neurologic examination of the lower extremities is completely normal. Laboratory studies show an erythrocyte sedimentation rate (ESR) of 85 mm/h85\text{ mm/h} and a C-reactive protein (CRP) level of 112 mg/L112\text{ mg/L}. Magnetic resonance imaging (MRI) of the thoracic spine demonstrates abnormal marrow signal and enhancement of the T10T10 and T11T11 vertebral bodies with a small adjacent fluid collection, diagnostic of vertebral osteomyelitis. Two sets of blood cultures are obtained, and the patient is started on empiric intravenous vancomycin and piperacillin-tazobactam. On hospital day 33, the patient's temperature is 37.4∘C37.4^\circ\text{C} (99.3∘F99.3^\circ\text{F}). Both sets of blood cultures are positive for Staphylococcus aureus that is susceptible to oxacillin, cefazolin, and vancomycin, but resistant to penicillin. Which of the following is the most appropriate next step in the pharmacologic management of this patient?

Show answer & explanation

Answer: Discontinue both current antibiotics and initiate intravenous cefazolin

Answer

Discontinue both current antibiotics and initiate intravenous cefazolin.
The most appropriate next step is to transition the patient to an intravenous anti-staphylococcal beta-lactam such as cefazolin. The patient has vertebral osteomyelitis and bacteremia caused by methicillin-susceptible Staphylococcus aureus (MSSA). Once culture susceptibilities confirm MSSA, antimicrobial stewardship principles dictate de-escalating from broad-spectrum empiric therapy to definitive, targeted therapy. For severe, deep-seated MSSA infections, beta-lactam antibiotics (e.g., cefazolin, nafcillin, oxacillin) are the standard of care because they demonstrate superior bactericidal activity, faster clearance of bacteremia, and lower mortality rates when compared to vancomycin.

Step-by-Step Solution

1
Analyze the culture and susceptibility data.
Blood cultures grew Staphylococcus aureus that is susceptible to oxacillin and cefazolin, definitively identifying the pathogen as methicillin-susceptible Staphylococcus aureus (MSSA).
Identifying the specific pathogen and its resistance profile is mandatory before adjusting empiric antibiotic therapy.
2
Apply principles of antimicrobial stewardship.
The broad-spectrum empiric regimen (vancomycin and piperacillin-tazobactam) must be de-escalated to a narrow-spectrum agent targeted at MSSA.
De-escalation minimizes drug toxicity, reduces collateral damage to the microbiome, and prevents the emergence of multidrug-resistant organisms.
3
Select the optimal definitive therapy for MSSA osteomyelitis.
Intravenous cefazolin (or nafcillin/oxacillin) is selected over vancomycin.
Anti-staphylococcal beta-lactams have superior bactericidal activity against MSSA compared to vancomycin, resulting in better clinical outcomes and faster bacterial clearance.

Key Concept

Antimicrobial Stewardship and MSSA Treatment
Question 406Question →

A 58-year-old man with a history of cavitary pulmonary tuberculosis presents to the emergency department after coughing up approximately 600 mL of bright red blood over the last 2 hours. He appears anxious and is in visible respiratory distress. His blood pressure is 88/55 mmHg, pulse is 122/min, and respiratory rate is 28/min. Auscultation reveals prominent coarse crackles over the right upper and middle lung fields, with clear breath sounds on the left. Arrange the following steps in the most appropriate sequential order for the management of this patient's condition.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: 1) Secure the airway and place in the right lateral decubitus position, 2) Establish intravenous access and administer volume resuscitation, 3) Perform urgent bronchoscopy, 4) Perform bronchial artery embolization.
The correct sequence for massive hemoptysis follows the standard airway, breathing, and circulation prioritization adapted for this specific emergency. First, the airway must be secured via intubation and the patient positioned with the bleeding lung down (right lateral decubitus in this case, given the right-sided crackles) to prevent blood from spilling into the healthy left lung. Second, circulation is addressed through intravenous access and fluid resuscitation to manage the hemorrhagic shock. Third, bronchoscopy is performed to clear the airway of clots, localize the specific bleeding site, and potentially apply local interventions. Finally, once the patient is stabilized and the source is localized, bronchial artery embolization is performed as the definitive therapy to stop the bleeding.

Step-by-Step Solution

1
Prioritize the airway and protect the non-bleeding lung.
The patient is intubated and placed in the right lateral decubitus position.
Asphyxiation from blood filling the alveoli is the leading cause of mortality in massive hemoptysis. Placing the bleeding lung dependent prevents spillage into the healthy lung.
2
Address the patient's hemodynamic instability.
Large-bore intravenous access is established and fluids or blood products are administered.
The patient has signs of hemorrhagic shock (blood pressure 88/55 mmHg) requiring immediate volume resuscitation after the airway is secured.
3
Identify the exact source of bleeding and provide local control.
Bronchoscopy is performed to visualize the airways.
Bronchoscopy localizes the bleeding to a specific lobe or segment and allows for interventions like ice-cold saline lavage or endobronchial balloon tamponade.
4
Provide definitive vascular control to stop the hemorrhage.
Bronchial artery embolization is performed.
Bronchial artery embolization is the standard definitive treatment for massive hemoptysis, which mostly originates from the high-pressure bronchial arterial circulation.

Key Concept

The most common cause of death in massive hemoptysis is asphyxiation, not exsanguination. Therefore, management must always prioritize airway security and protection of the non-bleeding lung before hemodynamic resuscitation, diagnostic localization, and definitive hemostasis.

Alternative Method

In cases where bronchial artery embolization is unavailable or unsuccessful, surgical lung resection (e.g., lobectomy) may be required as a salvage therapy.
Estimated Time:1m 30s
Question 407Question →

A 5555-year-old man comes to the clinic reporting a 66-month history of worsening fatigue, generalized weakness, and constipation. He also notes experiencing frequent dull headaches and has recently been bumping into doorframes while walking. His medical history is unremarkable, and he takes no medications. Vital signs are within normal limits. Physical examination reveals dry, cool skin and delayed relaxation of the deep tendon reflexes. Confrontation visual field testing demonstrates decreased peripheral vision bilaterally. Laboratory results are as follows:

Thyroid-stimulating hormone (TSH): 2.12.1 μ\mu U/mL (Normal: 0.50.5–5.05.0 μ\mu U/mL)
Free thyroxine (T4): 0.50.5 ng/dL (Normal: 0.90.9–2.42.4 ng/dL)

Which of the following is the most appropriate next step in evaluation?

Show answer & explanation

Answer: Magnetic resonance imaging of the pituitary gland

Answer

Magnetic resonance imaging of the pituitary gland
This patient presents with clinical signs of hypothyroidism (fatigue, constipation, delayed deep tendon reflexes) and a laboratory profile showing a low free T4 level with an inappropriately normal TSH. This pattern is diagnostic of central (secondary) hypothyroidism, indicating failure at the level of the pituitary or hypothalamus. Furthermore, his headaches and bitemporal hemianopsia (decreased peripheral vision causing him to bump into objects) indicate a mass lesion compressing the optic chiasm. The most likely underlying cause is a pituitary macroadenoma causing both hypopituitarism and mass effect. Therefore, the most appropriate next step is magnetic resonance imaging of the pituitary gland to visualize the sella turcica and the extent of optic chiasm compression.

Step-by-Step Solution

1
Interpret the patient's symptoms and physical examination findings.
The patient exhibits classic symptoms of hypothyroidism (fatigue, constipation, delayed reflexes). Additionally, headaches and bitemporal hemianopsia (bumping into doorframes) suggest a mass lesion compressing the optic chiasm.
Identifying both the endocrine and neurologic deficits narrows the differential diagnosis to a central structural cause.
2
Analyze the thyroid laboratory panel.
The free T4 is significantly low, but the TSH is inappropriately normal rather than elevated.
This pattern distinguishes secondary (central) hypothyroidism from primary thyroid failure, where TSH would be strongly elevated due to lack of negative feedback.
3
Determine the appropriate management based on the combined clinical picture.
The combination of central hypothyroidism and optic chiasm compression points to a pituitary macroadenoma, requiring urgent structural imaging.
Visualizing the sella turcica is critical for confirming the mass, assessing its extent, and planning potential surgical intervention before initiating hormone replacement therapy.

Key Concept

Diagnosis and management of central hypothyroidism secondary to a pituitary macroadenoma.
Question 408Question →

A 45-year-old woman is receiving a transfusion of packed red blood cells for severe anemia secondary to abnormal uterine bleeding. Thirty minutes into the transfusion, she develops sudden-onset chills, severe flank pain, and dyspnea. Her temperature is 39.2°C (102.6°F), blood pressure is 85/50 mm Hg, and heart rate is 120/min. Arrange the following management steps in the most appropriate chronological sequence.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence of management is: 1) Stop the transfusion immediately, 2) Initiate aggressive intravenous hydration, 3) Send samples and the blood unit to the blood bank, and 4) Monitor for systemic complications such as DIC.
This patient's presentation of sudden-onset fever, chills, flank pain, and hemodynamic instability shortly after beginning a blood transfusion is classic for an acute hemolytic transfusion reaction (AHTR), most commonly caused by ABO incompatibility due to a clerical error. The sequence of management prioritizes immediate cessation of harm, followed by physiological resuscitation, diagnostic confirmation, and finally, surveillance for downstream complications. Therefore, the transfusion must be stopped immediately. Next, aggressive intravenous fluid resuscitation with normal saline is paramount to manage shock and maintain brisk urine output, which prevents free hemoglobin from precipitating in the renal tubules and causing acute tubular necrosis. Only after the patient is hemodynamically supported should the provider focus on diagnostic steps, which include sending the remaining blood product and a new patient blood sample to the blood bank for a direct antiglobulin test (Coombs test) and repeat crossmatching. Finally, the patient must be continually monitored over the coming hours for the development of severe complications associated with AHTR, specifically acute kidney injury (AKI) and disseminated intravascular coagulation (DIC).

Step-by-Step Solution

1
Recognize the signs of an acute hemolytic transfusion reaction (fever, flank pain, hypotension) and immediately stop the transfusion.
Halts further administration of incompatible red blood cells.
To minimize the ongoing immune response and limit the severity of intravascular hemolysis.
2
Administer aggressive intravenous normal saline.
Restores intravascular volume and promotes brisk diuresis.
To correct hypotensive shock and flush the kidneys, preventing hemoglobin precipitation and acute tubular necrosis.
3
Send the remaining blood bag and a new patient blood sample to the blood bank.
Allows the laboratory to perform a direct antiglobulin test (DAT) and repeat crossmatching.
To definitively confirm the diagnosis of an immune-mediated acute hemolytic reaction, which is most often caused by a clerical error resulting in ABO incompatibility.
4
Monitor serial coagulation parameters and renal function.
Detects the onset of disseminated intravascular coagulation (DIC) or progressive acute kidney injury (AKI).
Massive release of red blood cell contents, including tissue factor-like substances, frequently triggers DIC, requiring ongoing surveillance after initial stabilization.

Key Concept

Management of Acute Hemolytic Transfusion Reaction (AHTR)
Question 409Question →

Review the following serum and urine laboratory profiles for four different adult patients. Reference ranges: Calcium 8.4-10.2 mg/dL, Intact PTH 10-65 pg/mL, Phosphorus 2.7-4.5 mg/dL, Creatinine 0.6-1.2 mg/dL; normal 24-hour urine calcium is typically 100-300 mg/day. Match each laboratory profile with the most likely clinical diagnosis.

Click a left item, then click its matching right item

Items

Profile A: Calcium 11.4 mg/dL, PTH 90 pg/mL, Phosphorus 2.0 mg/dL, Urine Calcium 350 mg/24h
Profile B: Calcium 10.9 mg/dL, PTH 75 pg/mL, Phosphorus 2.4 mg/dL, Urine Calcium 45 mg/24h
Profile C: Calcium 7.6 mg/dL, PTH 145 pg/mL, Phosphorus 5.8 mg/dL, Creatinine 3.4 mg/dL
Profile D: Calcium 7.8 mg/dL, PTH 11 pg/mL, Phosphorus 5.2 mg/dL, Creatinine 0.9 mg/dL

Matches

Show answer & explanation

Answer

Profile A matches Primary hyperparathyroidism, Profile B matches Familial hypocalciuric hypercalcemia, Profile C matches Secondary hyperparathyroidism due to chronic kidney disease, and Profile D matches Primary hypoparathyroidism.
The correct matches reflect the physiologic relationships between PTH, calcium, and phosphorus. Primary hyperparathyroidism involves autonomous PTH driving high serum calcium, low phosphorus, and high urine calcium. FHH shares the serum profile but features low urine calcium due to altered receptor sensing in the kidneys. CKD causes hypocalcemia and high phosphorus, which drives up PTH secondarily. Primary hypoparathyroidism involves a direct lack of PTH, causing hypocalcemia and hyperphosphatemia.

Step-by-Step Solution

1
Analyze Profile A and Profile B for causes of PTH-dependent hypercalcemia.
Both profiles show elevated calcium and elevated PTH. Profile A has a high urine calcium, whereas Profile B has a distinctly low urine calcium.
Measuring 24-hour urine calcium is the key step to differentiate primary hyperparathyroidism from familial hypocalciuric hypercalcemia (FHH).
2
Analyze Profile C and Profile D for causes of hypocalcemia.
Profile C has a high PTH alongside an elevated creatinine and high phosphorus. Profile D has a low PTH alongside normal creatinine.
PTH levels differentiate secondary hyperparathyroidism (high PTH functioning as an appropriate response to renal failure-induced hypocalcemia) from primary hypoparathyroidism (failure of parathyroid glands to produce PTH).

Key Concept

Differential diagnosis of calcium and parathyroid hormone disorders utilizing serum chemistries and urinary calcium excretion.
Question 410Question →

Match the following arterial blood gas and serum electrolyte profiles with their most likely underlying clinical etiology.

Click a left item, then click its matching right item

Items

pH:7.32\text{pH}: 7.32, PaCO2:28 mmHg\text{PaCO}_2: 28\text{ mmHg}, HCO3−:14 mEq/L\text{HCO}_3^-: 14\text{ mEq/L}, Na+:140 mEq/L\text{Na}^+: 140\text{ mEq/L}, Cl−:115 mEq/L\text{Cl}^-: 115\text{ mEq/L}
pH:7.46\text{pH}: 7.46, PaCO2:20 mmHg\text{PaCO}_2: 20\text{ mmHg}, HCO3−:14 mEq/L\text{HCO}_3^-: 14\text{ mEq/L}, Na+:142 mEq/L\text{Na}^+: 142\text{ mEq/L}, Cl−:105 mEq/L\text{Cl}^-: 105\text{ mEq/L}
pH:7.26\text{pH}: 7.26, PaCO2:25 mmHg\text{PaCO}_2: 25\text{ mmHg}, HCO3−:11 mEq/L\text{HCO}_3^-: 11\text{ mEq/L}, Na+:138 mEq/L\text{Na}^+: 138\text{ mEq/L}, Cl−:100 mEq/L\text{Cl}^-: 100\text{ mEq/L}
pH:7.33\text{pH}: 7.33, PaCO2:60 mmHg\text{PaCO}_2: 60\text{ mmHg}, HCO3−:31 mEq/L\text{HCO}_3^-: 31\text{ mEq/L}, Na+:138 mEq/L\text{Na}^+: 138\text{ mEq/L}, Cl−:97 mEq/L\text{Cl}^-: 97\text{ mEq/L}
pH:7.50\text{pH}: 7.50, PaCO2:48 mmHg\text{PaCO}_2: 48\text{ mmHg}, HCO3−:36 mEq/L\text{HCO}_3^-: 36\text{ mEq/L}, Na+:140 mEq/L\text{Na}^+: 140\text{ mEq/L}, Cl−:94 mEq/L\text{Cl}^-: 94\text{ mEq/L}

Matches

Show answer & explanation

Answer

Profile 1 corresponds to laxative consumption (normal gap acidosis), Profile 2 to salicylate toxicity (mixed disorder), Profile 3 to insulin deficiency (high gap acidosis), Profile 4 to obstructive airway disease (chronic respiratory acidosis), and Profile 5 to prolonged emesis (metabolic alkalosis).
Each profile uniquely identifies a distinct acid-base disturbance. Applying the principles of anion gap calculation and expected respiratory compensation separates the varying etiologies accurately.

Step-by-Step Solution

1
Calculate the anion gap for every profile using the formula Na+−(Cl−+HCO3−)\text{Na}^+ - (\text{Cl}^- + \text{HCO}_3^-).
Profile 1: 1111, Profile 2: 2323, Profile 3: 2727, Profile 4: 1010, Profile 5: 1010.
Determining the anion gap is an essential first step in evaluating any acid-base disorder, revealing hidden metabolic derangements even when the pH is alkalemic.
2
Determine the primary acid-base disturbance by examining the pH in conjunction with the changes in PaCO2 and HCO3-.
Profiles 1 and 3 are primary metabolic acidoses. Profile 2 is a mixed primary respiratory alkalosis and primary metabolic acidosis. Profile 4 is a primary respiratory acidosis. Profile 5 is a primary metabolic alkalosis.
Identifying the primary physiological disturbance dictates which secondary compensatory formulas must be applied.
3
Apply Winter's formula (1.5×HCO3−+8±21.5 \times \text{HCO}_3^- + 8 \pm 2) to the patients with metabolic acidosis.
For Profile 3, the predicted PaCO2\text{PaCO}_2 is 24.5 mmHg24.5\text{ mmHg}, matching the measured 25 mmHg25\text{ mmHg} (simple compensated high gap acidosis). For Profile 2, the predicted PaCO2\text{PaCO}_2 is 29 mmHg29\text{ mmHg}, but the measured is 20 mmHg20\text{ mmHg}, confirming an additional primary respiratory alkalosis.
This mathematical step definitively distinguishes simple, appropriately compensated acid-base disorders from complex mixed disorders.
4
Correlate the mathematical acid-base diagnoses with the provided pathophysiological states.
Normal gap acidosis matches intestinal bicarbonate loss. High gap acidosis matches ketone production. The mixed respiratory alkalosis and high gap acidosis matches acetylsalicylic acid toxicity. Chronic compensated respiratory acidosis matches COPD. Metabolic alkalosis matches gastric acid loss.
Final confirmation requires aligning the objective laboratory values with the clinical mechanism of disease.

Key Concept

Diagnosis of complex and mixed acid-base disorders using the anion gap, Winter's formula, and compensation rules.
Question 411Question →

An emergency department physician evaluates a 69-year-old female resident of an assisted living facility who presents with a 4-day history of profuse, watery diarrhea and progressively worsening shortness of breath. She has a medical history of chronic obstructive pulmonary disease (COPD) and heart failure with reduced ejection fraction. She reports an increase in cough and purulent sputum production that began one week ago. Three days ago, her primary care physician obtained a sputum culture that subsequently grew *Moraxella catarrhalis* sensitive to amoxicillin, azithromycin, and cefuroxime.

Vital signs are as follows:
ParameterValue
Temperature37.1°C (98.8°F)
Blood pressure95/60 mm Hg
Heart rate112/min
Respiratory rate26/min
Oxygen saturation89% (room air)

Physical examination reveals dry oral mucosa and flat neck veins when supine. Lung auscultation demonstrates scattered expiratory wheezes and a prolonged expiratory phase, without crackles. Cardiac examination shows a regular tachycardia with no S3 gallop.

Laboratory results:
TestResult
Sodium134 mEq/L
Potassium3.2 mEq/L
Chloride110 mEq/L
Bicarbonate14 mEq/L
Blood urea nitrogen45 mg/dL
Creatinine1.8 mg/dL
Arterial blood gas (room air):
ParameterValue
pH7.32
PaCO2_229 mm Hg
PaO2_258 mm Hg

Which of the following are appropriate next steps in the management of this patient? (Select all that apply)

Select all that apply

Show answer & explanation

Answer: Initiate isotonic crystalloid infusion; Start azithromycin therapy

Answer

The correct interventions are to initiate isotonic crystalloid infusion to correct the severe hypovolemia and to start azithromycin therapy to treat the triggered COPD exacerbation.
This patient presents with a primary non-anion gap metabolic acidosis due to gastrointestinal bicarbonate loss from severe diarrhea, compounded by a COPD exacerbation. Her physical examination reveals clear signs of hypovolemia (flat neck veins, dry oral mucosa, tachycardia, hypotension, and a BUN-to-creatinine ratio greater than 20:1), indicating a critical need for aggressive fluid resuscitation with isotonic crystalloids. Additionally, her COPD exacerbation is triggered by a documented *Moraxella catarrhalis* infection. Based on the susceptibility results provided by her primary care physician, starting a targeted antibiotic such as azithromycin is the standard of care.

Step-by-Step Solution

1
Analyze the patient's volume status and cardiac function based on physical exam and basic metabolic panel.
The patient is severely hypovolemic (hypotension, tachycardia, BUN/Cr ratio > 20, flat neck veins, dry mucosa) due to gastrointestinal losses, ruling out acute decompensated heart failure.
Distinguishing between a COPD exacerbation and a heart failure exacerbation is critical, as giving diuretics to a hypovolemic patient is dangerous.
2
Evaluate the acid-base status using the arterial blood gas and basic metabolic panel.
The patient has a primary non-anion gap metabolic acidosis (HCO 3−_3^- = 1414 mEq/L) driven by diarrhea. Using Winter's formula (1.5×14+8=29±21.5 \times 14 + 8 = 29 \pm 2), the expected PaCO 2_2 is 2727 to 3131 mm Hg, which matches her actual PaCO 2_2 of 2929 mm Hg.
Determining if the respiratory compensation is adequate helps avoid inappropriate interventions like mechanical ventilation aimed at artificially "normalizing" the PaCO 2_2.
3
Determine the appropriate antibiotic therapy based on culture results.
The prior sputum culture identified *Moraxella catarrhalis* sensitive to azithromycin. A targeted agent is appropriate, whereas broad-spectrum agents are unnecessary.
Adhering to antibiotic stewardship prevents resistance and complications like *Clostridioides difficile* infection.

Key Concept

Management of combined hypovolemic shock, perfectly compensated metabolic acidosis, and targeted COPD exacerbation therapy.
Estimated Time:2m 0s
Question 412Question →

A 29-year-old woman is evaluated in the clinic for a 4-month history of rapidly progressive facial hair growth, severe acne, and absent menses. Prior to this, she had regular 28-day menstrual cycles. The patient also reports recent deepening of her voice. She takes no medications and has no chronic medical conditions. Her BMI is 24 kg/m224 \text{ kg/m}^2, and her blood pressure is 115/75 mmHg115/75 \text{ mmHg}. Physical examination reveals coarse, dark terminal hair on her chin, chest, and lower abdomen. Temporal hair thinning is noted. Pelvic examination is remarkable for clitoromegaly. A urine pregnancy test is negative.

Laboratory studies show:
- Serum total testosterone: 155 ng/dL155 \text{ ng/dL} (normal: 15−70 ng/dL15-70 \text{ ng/dL})
- Dehydroepiandrosterone sulfate (DHEAS): 8,200 \mug/dL8,200 \text{ \mu g/dL} (normal: 35−430 \mug/dL35-430 \text{ \mu g/dL})
- Thyroid-stimulating hormone (TSH): 2.2 \muU/mL2.2 \text{ \mu U/mL} (normal: 0.5−5.0 \muU/mL0.5-5.0 \text{ \mu U/mL})
- Prolactin: 12 ng/mL12 \text{ ng/mL} (normal: 4−24 ng/mL4-24 \text{ ng/mL})

Which of the following is the most likely diagnosis?

Show answer & explanation

Answer: Androgen-secreting adrenal tumor

Answer

Androgen-secreting adrenal tumor
The correct answer identifies an adrenal tumor as the source. This patient presents with rapid-onset, severe virilization (deepening voice, clitoromegaly, temporal balding), which is a red flag for an androgen-secreting neoplasm. Furthermore, her laboratory tests show an extremely high level of dehydroepiandrosterone sulfate (DHEAS). Because DHEAS is produced almost exclusively by the adrenal glands, a markedly elevated level (typically >700 \mug/dL>700 \text{ \mu g/dL}) strongly points to an androgen-secreting adrenal tumor (e.g., adrenocortical carcinoma) as the specific cause, rather than an ovarian source.

Step-by-Step Solution

1
Analyze the clinical history and physical examination findings.
The patient has a 4-month history of rapidly progressive virilization, including clitoromegaly, temporal balding, and a deepened voice.
Differentiating simple hyperandrogenism from true, rapid virilization is the critical first step to identifying an androgen-secreting neoplasm.
2
Evaluate the provided laboratory values.
Serum testosterone is elevated (155 ng/dL155 \text{ ng/dL}) and DHEAS is markedly elevated (8,200 \mug/dL8,200 \text{ \mu g/dL}).
Specific androgen markers help localize the source of the excess hormone.
3
Correlate the laboratory markers with their physiologic sources.
The extreme elevation of DHEAS, which is exclusively produced by the adrenal glands, confirms an adrenal source rather than an ovarian source.
Ovarian tumors would present with high testosterone but normal DHEAS levels.

Key Concept

Rapid-onset virilization combined with a markedly elevated DHEAS level is highly specific for an androgen-secreting adrenal tumor.
Question 413Question →

A 67-year-old man is brought to the emergency department from his home by his daughter due to progressive confusion, a productive cough with rust-colored sputum, and subjective fever for the past 3 days. He has a history of severe obesity hypoventilation syndrome, untreated obstructive sleep apnea, and chronic lower extremity edema.

Vital signs include a temperature of 38.8∘C38.8^\circ C (101.8∘F101.8^\circ F), heart rate of 115115/min, blood pressure of 105/65105/65 mmHg, respiratory rate of 2424/min, and oxygen saturation of 82%82\% on room air.

Physical examination reveals a body mass index of 4242 kg/m 2^2. The patient is lethargic but rousable. Jugular venous distention is present to the angle of the jaw. Chest auscultation reveals bronchial breath sounds and egophony in the right lower lobe, along with trace bilateral expiratory wheezing; no fine crackles are heard. Cardiac examination reveals a prominent P2P_2 and a right-sided S3S_3. There is 3+3+ pitting edema bilaterally up to the knees.

Laboratory results:
Leukocyte count: 16,500/μL16,500/\mu L (with 12%12\% bands)
Serum sodium: 138138 mEq/L
Serum potassium: 4.14.1 mEq/L
Serum chloride: 9292 mEq/L
Serum bicarbonate: 1616 mEq/L
Blood urea nitrogen: 3232 mg/dL
Serum creatinine: 1.41.4 mg/dL
Serum lactate: 4.24.2 mmol/L

Arterial blood gas (on room air):
pH: 7.137.13
PaO 2_2: 5050 mm Hg
PaCO 2_2: 5050 mm Hg

Chest radiograph shows a dense right lower lobe consolidation. There is prominent central pulmonary vasculature and right ventricular enlargement, but no pulmonary venous congestion or pleural effusion.

A rapid lower respiratory tract multiplex PCR panel is positive for *Streptococcus pneumoniae* and negative for all other bacterial and viral targets.

Based on the patient's presentation and diagnostic findings, which of the following statements are correct regarding his diagnosis and management? (Select all that apply)

Select all that apply

Show answer & explanation

Answer: The arterial blood gas analysis demonstrates a primary metabolic acidosis with a concurrent primary respiratory acidosis.; The elevated jugular venous pressure and bilateral pitting edema represent right ventricular failure secondary to chronic hypoxic pulmonary vasoconstriction.; Antimicrobial therapy should consist of targeted coverage for Streptococcus pneumoniae, such as ceftriaxone, rather than empiric broad-spectrum agents.

Answer

The correct statements are that the ABG shows a primary metabolic acidosis with a concurrent primary respiratory acidosis, the physical exam findings represent right ventricular failure (cor pulmonale) from chronic hypoxia, and antimicrobial therapy should be targeted for Streptococcus pneumoniae.
The correct statements accurately interpret three key domains of this patient's presentation. First, the ABG shows a pH of 7.13 and HCO3 of 16 mEq/L, indicating a metabolic acidosis (likely lactic acidosis given the lactate of 4.2). Using Winter's formula, the expected PaCO2 is (1.5 * 16) + 8 = 32 +/- 2 mm Hg. The patient's actual PaCO2 is 50 mm Hg, diagnosing a concurrent primary respiratory acidosis. Second, the clinical signs of JVD, right-sided S3, and edema, coupled with clear lungs (no crackles) and a chest X-ray showing RV enlargement without venous congestion, are diagnostic of Cor Pulmonale (right heart failure). Finally, the rapid PCR directly isolates S. pneumoniae, meaning targeted therapy is indicated over broad-spectrum empiric coverage.

Step-by-Step Solution

1
Analyze the arterial blood gas values to determine the primary and secondary acid-base disturbances.
The patient has a primary metabolic acidosis (pH 7.13, HCO3 16 mEq/L) with a concurrent primary respiratory acidosis (PaCO2 50 mm Hg).
Applying Winter's formula (Expected PaCO2 = 1.5 * HCO3 + 8 +/- 2) yields an expected PaCO2 of 30-34 mm Hg. Because the actual PaCO2 is 50 mm Hg, respiratory compensation is inadequate, indicating a mixed acid-base disorder.
2
Interpret the physical exam and imaging findings to differentiate the etiology of the heart failure signs.
The findings are consistent with isolated right heart failure (Cor Pulmonale).
The patient has jugular venous distention, peripheral edema, and a right-sided S3, but lacks fine crackles on exam and lacks pulmonary venous congestion on chest X-ray. This differentiates his chronic right heart strain (from obesity hypoventilation syndrome) from acute left heart failure.
3
Determine the appropriate antimicrobial regimen based on the clinical setting and microbiological data.
Targeted therapy with an agent like ceftriaxone is indicated.
The patient has community-acquired pneumonia, and a multiplex PCR specifically identified S. pneumoniae while ruling out MRSA and Pseudomonas. Initiating broad-spectrum agents in this scenario violates antibiotic stewardship principles.

Key Concept

Management of complex respiratory failure requires systematic interpretation of acid-base status using Winter's formula, clinical differentiation of right versus left heart failure, and adherence to antibiotic stewardship when microbiological data is available.
Estimated Time:2m 0s
Question 414Question →

A 71-year-old man is transported to the hospital by emergency medical services due to the abrupt onset of severe difficulty breathing. Three days ago, the patient experienced a prolonged episode of substernal discomfort and diaphoresis but declined to seek medical care, assuming it was severe heartburn. His medical history includes hypertension, hyperlipidemia, and a 45-pack-year history of smoking.

On arrival, his blood pressure is 88/54 mm Hg, heart rate is 118/min, and respiratory rate is 26/min. Oxygen saturation is 86% on room air. The patient is diaphoretic and unable to speak in full sentences. Neck veins are distended. Lung auscultation reveals diffuse bilateral crackles and prominent expiratory wheezing. Cardiac examination demonstrates a rapid regular rhythm with a loud, blowing holosystolic murmur that is most prominent at the cardiac apex and radiates to the left axilla.

An electrocardiogram displays normal sinus rhythm with prominent Q waves and inverted T waves in leads II, III, and aVF.

Based on the clinical presentation, which of the following is the most likely etiology of this patient's acute respiratory distress?

Show answer & explanation

Answer: Ischemic rupture of the posteromedial papillary muscle

Answer

The most likely etiology is ischemic rupture of the posteromedial papillary muscle, leading to acute severe mitral regurgitation and subsequent cardiogenic pulmonary edema.
The correct answer is ischemic rupture of the posteromedial papillary muscle. This patient presents with acute cardiogenic shock and severe pulmonary edema 3 days after an unmanaged inferior myocardial infarction (evidenced by Q waves in leads II, III, and aVF). The posteromedial papillary muscle is particularly vulnerable to ischemia because it receives a single blood supply from the posterior descending artery (typically a branch of the right coronary artery). Rupture of this muscle leads to acute, severe mitral regurgitation, producing a classic harsh holosystolic murmur at the apex that radiates to the axilla. The sudden regurgitant volume rapidly increases left atrial pressure, leading to acute cardiogenic pulmonary edema. This edema fluid in the airways can cause bronchospasm and wheezing, often referred to as 'cardiac asthma'.

Step-by-Step Solution

1
Analyze the patient's history and electrocardiogram findings.
The patient had prolonged chest pain 3 days ago, and the ECG shows Q waves in leads II, III, and aVF, indicating a recent inferior myocardial infarction.
Identifying the timing and location of the myocardial infarction is critical for predicting specific post-infarction mechanical complications.
2
Evaluate the new physical examination findings.
The patient presents with cardiogenic shock (hypotension, tachycardia) and a new, loud holosystolic murmur at the apex radiating to the axilla, which is classic for mitral regurgitation.
Different mechanical complications of MI produce distinct murmurs and hemodynamic profiles.
3
Synthesize the findings to determine the primary cause of the respiratory distress.
An inferior MI often involves the right coronary artery, which provides the sole blood supply to the posteromedial papillary muscle. Rupture of this muscle causes acute severe mitral regurgitation, rapid left atrial volume overload, and subsequent acute pulmonary edema (manifesting as crackles and wheezing, or 'cardiac asthma').
Connecting the inferior MI to its most common structural complication explains all the patient's symptoms, including the pulmonary findings.

Key Concept

Post-myocardial infarction mechanical complications: Posteromedial papillary muscle rupture.
Estimated Time:1m 30s
Question 415Question →

Match each HIV-positive patient's clinical presentation and neuroimaging or cerebrospinal fluid (CSF) finding with the most likely causative pathogen or etiology.

Click a left item, then click its matching right item

Items

A 35-year-old with a CD4 count of 45 cells/μL45 \text{ cells}/\mu\text{L} presents with new-onset seizures. Brain MRI shows multiple ring-enhancing lesions primarily in the basal ganglia with surrounding edema.
A 42-year-old with a CD4 count of 30 cells/μL30 \text{ cells}/\mu\text{L} presents with progressive hemiparesis and speech difficulty. Brain MRI reveals asymmetric, non-enhancing white matter lesions without mass effect.
A 38-year-old with a CD4 count of 80 cells/μL80 \text{ cells}/\mu\text{L} presents with headache, fever, and neck stiffness. CSF analysis demonstrates an elevated opening pressure and is positive for encapsulated yeast organisms on India ink stain.
A 40-year-old with a CD4 count of 20 cells/μL20 \text{ cells}/\mu\text{L} presents with progressive confusion. Brain MRI shows a solitary, weakly ring-enhancing periventricular mass. CSF polymerase chain reaction is positive for a specific oncogenic virus.

Matches

Show answer & explanation

Answer

The correct matches correlate characteristic neuroradiological and CSF findings with their specific opportunistic etiologies: multiple ring-enhancing lesions match with Toxoplasma gondii, non-enhancing white matter lesions match with JC virus, elevated CSF opening pressure with encapsulated yeast matches with Cryptococcus neoformans, and a solitary periventricular mass with oncogenic viral DNA matches with Epstein-Barr virus.
In advanced HIV, distinct CNS pathogens produce hallmark clinical and radiological phenotypes. Toxoplasma gondii causes multiple ring-enhancing lesions. JC virus targets oligodendrocytes, causing non-enhancing white matter demyelination without mass effect (PML). Cryptococcus neoformans causes meningoencephalitis with characteristically high opening pressure. Epstein-Barr virus drives Primary CNS Lymphoma, typically appearing as a single periventricular mass.

Step-by-Step Solution

1
Analyze the CD4 count and immune status of each patient in the vignettes.
All patients have advanced AIDS (CD4 < 100 cells/µL), putting them at risk for severe central nervous system opportunistic infections.
CD4 counts stratify the risk for specific opportunistic pathogens, helping to narrow the differential diagnosis.
2
Evaluate the MRI and CSF descriptions for classic pathognomonic patterns.
Basal ganglia ring-enhancing lesions point to toxoplasmosis; non-enhancing white matter lesions to progressive multifocal leukoencephalopathy (PML); encapsulated yeast to cryptococcosis; and a solitary periventricular mass to primary CNS lymphoma.
Neuroimaging patterns and basic CSF stains are the primary non-invasive diagnostic differentiators for HIV-associated CNS lesions.

Key Concept

Diagnosis of central nervous system opportunistic infections in HIV/AIDS based on neuroimaging and cerebrospinal fluid analysis.
Estimated Time:1m 30s
Question 416Question →

The triage nurse calls a physician to evaluate a newly arrived patient in the emergency department. The patient, a 34-year-old woman with no significant past medical history, describes a rapidly progressive, profound exhaustion over the last 72 hours, accompanied by intermittent episodes of confusion and 'purple spots' appearing on her legs.

Vital signs include a heart rate of 108/min, blood pressure of 142/88 mmHg, temperature of 37.8°C (100.0°F), and oxygen saturation of 98% on room air. Examination shows widespread lower extremity petechiae, mild scleral icterus, and temporal disorientation without focal neurological deficits.

Initial laboratory studies report:
TestResultReference Range
Hemoglobin7.6 g/dL12.0-15.5 g/dL
Platelet count18,000/mm³150,000-400,000/mm³
Leukocyte count8,400/mm³4,500-11,000/mm³
Creatinine1.3 mg/dL0.6-1.1 mg/dL
Total bilirubin3.2 mg/dL0.1-1.2 mg/dL
Indirect bilirubin2.8 mg/dL0.1-0.8 mg/dL
Lactate dehydrogenase (LDH)1,150 U/L140-280 U/L
Prothrombin time (PT)12 sec11-15 sec
Activated PTT (aPTT)30 sec25-40 sec

Based on the clinical presentation and initial laboratory data, arrange the following diagnostic and therapeutic steps in the strictly required chronological sequence to properly manage this patient's suspected hematologic emergency.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: 1) Evaluate a peripheral blood smear to confirm MAHA, 2) Draw blood samples for ADAMTS13 activity, 3) Initiate urgent therapeutic plasma exchange (TPE), and 4) Monitor daily platelet counts and LDH levels.
In a patient presenting with the classic features of TTP—thrombocytopenia, microangiopathic hemolytic anemia (MAHA), and neurologic deficits without severe coagulation factor consumption (normal PT/aPTT)—the initial diagnostic step is confirming MAHA via a peripheral blood smear. Once clinically suspected, the absolute next critical step is drawing blood for ADAMTS13 activity and inhibitor testing. This MUST occur before any plasma is administered to avoid false-negative results. Immediately following the blood draw, empirical therapeutic plasma exchange (TPE) is initiated to remove the offending autoantibody and supply functional ADAMTS13. TPE should never be delayed pending assay results. Finally, disease response is tracked using daily platelet counts and LDH levels.

Step-by-Step Solution

1
Evaluate a peripheral blood smear
Confirmation of schistocytes
Establishes the presence of microangiopathic hemolytic anemia, which, alongside severe thrombocytopenia and normal coagulation studies, strongly suggests Thrombotic Thrombocytopenic Purpura (TTP).
2
Draw blood samples for ADAMTS13
Secures the unadulterated baseline enzyme level
Must be performed prior to any plasma infusion; donor plasma contains ADAMTS13 and will artificially normalize the patient's test results, obscuring the definitive diagnosis.
3
Initiate therapeutic plasma exchange (TPE)
Removal of ADAMTS13 inhibitors and replacement of functional enzyme
TTP is rapidly fatal if untreated. TPE must be started empirically immediately after blood draws, as ADAMTS13 results typically take days to return.
4
Monitor platelets and LDH
Assessment of disease activity and treatment efficacy
Guides the continuation, tapering, or modification of TPE and adjunctive immunosuppressive therapy.

Key Concept

The strict sequential management of suspected Thrombotic Thrombocytopenic Purpura (TTP) requires confirming MAHA, drawing an ADAMTS13 level prior to any plasma exposure, and immediately initiating empirical therapeutic plasma exchange.
Question 417Question →

A 2828-year-old woman with a history of ulcerative colitis presents to the emergency department with a 44-day history of 88 to 1010 bloody bowel movements daily, severe abdominal cramps, and subjective fever. Her temperature is 38.4∘C38.4^\circ\text{C} (101.1∘F101.1^\circ\text{F}), pulse is 112/min112/\text{min}, and blood pressure is 105/65 mm Hg105/65\text{ mm Hg}. Physical examination reveals diffuse lower abdominal tenderness without rebound or guarding. Laboratory studies show a hemoglobin of 9.8 g/dL9.8\text{ g/dL}, leukocyte count of 14,500/mm314,500/\text{mm}^3, and C-reactive protein of 65 mg/L65\text{ mg/L}. She meets the Truelove and Witts criteria for acute severe ulcerative colitis. Arrange the following diagnostic and therapeutic steps in the optimal chronological sequence for the management of this patient.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: 1) Obtain an abdominal radiograph and stool assays, 2) Initiate high-dose intravenous corticosteroid therapy, 3) Assess for objective clinical response at 72 hours, 4) Administer medical rescue therapy, 5) Proceed with urgent total abdominal colectomy.
The management of acute severe ulcerative colitis follows a strict, step-wise algorithm designed to induce rapid remission while minimizing the risk of life-threatening complications. Initial steps must prioritize ruling out contraindications to immunosuppression (e.g., infection, megacolon), followed immediately by the first-line standard of care (intravenous corticosteroids). Because a significant proportion of patients are steroid-refractory, a scheduled reassessment at 72 hours is mandatory. Failure at this juncture dictates the use of biologic or immunomodulator rescue therapies, with surgery reserved as the final definitive option for medical failure.

Step-by-Step Solution

1
Exclude infectious triggers and anatomical complications.
An abdominal radiograph rules out toxic megacolon, and stool assays evaluate for superimposed Clostridioides difficile infection.
Administering high-dose immunosuppression in the presence of megacolon or active C. difficile can lead to fatal bowel perforation.
2
Begin primary induction therapy.
Intravenous methylprednisolone or hydrocortisone is administered.
Intravenous corticosteroids are the cornerstone of treatment for acute severe ulcerative colitis (ASUC) without immediate surgical indications.
3
Evaluate steroid responsiveness.
Clinical status, including stool frequency and C-reactive protein levels, is formally assessed at hospital day 3.
Approximately 30-40% of patients are steroid-refractory; early and objective identification allows prompt escalation of therapy.
4
Initiate second-line medical induction.
Infliximab or cyclosporine is given as rescue therapy.
Medical rescue therapy is necessary for patients failing intravenous steroids to prevent the need for immediate colectomy.
5
Perform surgical management.
Total abdominal colectomy is performed.
Surgery is the definitive treatment if all medical rescue therapies fail or if acute surgical indications (e.g., toxic megacolon, perforation) arise at any point during hospitalization.

Key Concept

The step-wise management of acute severe ulcerative colitis involves ruling out contraindications, initiating intravenous steroids, assessing response at 72 hours, escalating to rescue biologics if refractory, and reserving colectomy for medical failure.
Estimated Time:1m 30s
Question 418Question →

Match each patient's clinical presentation with the most appropriate initial or definitive targeted pharmacotherapy.

Click a left item, then click its matching right item

Items

A 34-year-old man with a history of renal transplantation presents with fever, pleuritic chest pain, and hemoptysis. Chest CT reveals a dense nodule with a surrounding halo of ground-glass opacity. Serum galactomannan assay is positive.
A 52-year-old woman with diabetic ketoacidosis presents with unilateral facial pain, periorbital edema, and a black necrotic eschar on the nasal turbinate. Biopsy shows broad, nonseptate hyphae branching at wide angles.
A 41-year-old forestry worker from Wisconsin presents with a chronic cough, low-grade fever, and ulcerated, verrucous skin lesions on his arms. Sputum microscopy reveals large yeast cells with broad-based budding.
A 29-year-old man with HIV and a CD4 count of 40 cells/mm³ presents with fever, insidious onset of severe headache, and lethargy. CSF analysis shows elevated opening pressure and a profoundly positive cryptococcal antigen test. He is treatment-naïve.

Matches

Show answer & explanation

Answer

Invasive aspergillosis is treated with Voriconazole. Mucormycosis is treated with Liposomal amphotericin B and surgical debridement. Mild-to-moderate Blastomycosis is treated with Itraconazole. Cryptococcal meningitis is treated with Liposomal amphotericin B and flucytosine.
Each fungal pathogen has a distinct targeted therapy based on its intrinsic susceptibilities, the severity of illness, and the site of infection. Invasive aspergillosis requires voriconazole. Mucormycosis requires a combined medical (liposomal amphotericin B) and surgical approach. Mild-to-moderate blastomycosis responds well to itraconazole. Cryptococcal meningitis induction requires a fungicidal regimen of liposomal amphotericin B and flucytosine to rapidly clear the central nervous system.

Step-by-Step Solution

1
Analyze the first clinical presentation to identify the pathogen and treatment.
The renal transplant patient with hemoptysis, a 'halo sign' on CT, and a positive galactomannan assay has invasive aspergillosis, which is treated with voriconazole.
Voriconazole provides superior survival benefits for invasive Aspergillus infections compared to other systemic antifungals.
2
Evaluate the second vignette for diagnosis and management.
The patient with diabetic ketoacidosis, a nasal eschar, and right-angle branching nonseptate hyphae has mucormycosis. This requires liposomal amphotericin B and urgent surgical debridement.
Medical therapy alone cannot penetrate the necrotic, ischemic tissue characteristic of mucormycosis; surgical removal of the infected tissue is mandatory.
3
Identify the pathogen in the third scenario and its corresponding therapy.
The forestry worker from Wisconsin with chronic cough, verrucous skin lesions, and broad-based budding yeast has mild-to-moderate blastomycosis, correctly treated with oral itraconazole.
Itraconazole is highly effective and the drug of choice for non-life-threatening, non-CNS endemic mycoses.
4
Assess the fourth vignette to determine the appropriate induction therapy.
The HIV patient with advanced immunosuppression, headache, and positive CSF cryptococcal antigen has cryptococcal meningitis. Standard induction therapy is liposomal amphotericin B combined with flucytosine.
This combination rapidly sterilizes the cerebrospinal fluid and significantly reduces mortality during the induction phase (typically the first two weeks).

Key Concept

Targeted Antifungal Pharmacotherapy for Systemic and Opportunistic Mycoses
Question 419Question →

Match each clinical presentation of a hereditary gastrointestinal polyposis or cancer syndrome to its corresponding underlying molecular genetic defect.

Click a left item, then click its matching right item

Items

A 24-year-old male with hematochezia has over 200 colonic adenomas. He recently had a mandibular osteoma removed, and funduscopic examination reveals congenital hypertrophy of the retinal pigment epithelium.
A 39-year-old female is diagnosed with endometrial carcinoma. Her father died of proximal colon cancer at age 44. Colonoscopy reveals a solitary, right-sided sessile polyp.
A 21-year-old female requires surgery for small bowel intussusception due to jejunal hamartomas. She has distinct dark blue-brown macules on her buccal mucosa and lips.
A 48-year-old male has 45 adenomatous colonic polyps. He has no family history of colon cancer, and both parents lived into their 80s. Genetic testing for a common dominant adenomatous polyposis gene is negative.
A 42-year-old male with macrocephaly has asymptomatic colonic hamartomas. Skin examination reveals facial trichilemmomas and acral keratoses. He has a prior history of follicular thyroid carcinoma.

Matches

Show answer & explanation

Answer

The patient with over 200 adenomas and CHRPE (Gardner syndrome) matches defective Wnt/beta-catenin signaling. The patient with endometrial cancer and a family history of colon cancer (Lynch syndrome) matches the mismatch repair defect. The patient with jejunal hamartomas and mucosal hyperpigmentation (Peutz-Jeghers syndrome) matches the STK11 mutation. The patient with 45 adenomas and an autosomal recessive pattern (MUTYH-associated polyposis) matches the base excision repair defect. The patient with macrocephaly, trichilemmomas, and thyroid cancer (Cowden syndrome) matches the PTEN mutation.
Each clinical presentation distinctly describes a specific hereditary gastrointestinal polyposis or cancer syndrome, which must be matched with its exact underlying molecular genetic defect.

SyndromeGene / PathwayInheritanceGI FindingsKey Extraintestinal Manifestations
FAP / GardnerAPC (Wnt/beta-catenin)Dominant>100 adenomasOsteomas, CHRPE, desmoid tumors
Lynch SyndromeMLH1, MSH2 (Mismatch repair)DominantFew polyps, rapid sequenceEndometrial, ovarian cancer
Peutz-JeghersSTK11 (Serine/threonine kinase)DominantHamartomasMucocutaneous hyperpigmentation
MUTYH PolyposisMUTYH (Base excision repair)Recessive10-100 adenomasNone specific
Cowden SyndromePTEN (Lipid phosphatase)DominantHamartomasMacrocephaly, trichilemmomas, thyroid cancer
Identifying these subtle extraintestinal signs is critical for differentiating the conditions and determining the correct genetic workup.

Step-by-Step Solution

1
Analyze the first clinical vignette to diagnose the syndrome and identify its genetic basis.
Over 200 adenomas, osteomas, and CHRPE indicate Gardner syndrome (FAP variant), caused by an APC mutation leading to aberrant Wnt/beta-catenin signaling.
Identifying the distinct extraintestinal manifestations is necessary to differentiate FAP from other polyposis syndromes.
2
Evaluate the second vignette focusing on the patient's personal and family cancer history.
Early-onset right-sided colon cancer and endometrial cancer point to Lynch syndrome, caused by a DNA mismatch repair defect.
Lynch syndrome is the most common inherited colorectal cancer syndrome and does not present with diffuse polyposis.
3
Assess the third vignette featuring gastrointestinal intussusception and distinct skin findings.
Jejunal hamartomas and perioral hyperpigmentation are pathognomonic for Peutz-Jeghers syndrome, caused by STK11 mutations.
Hamartomatous polyposis syndromes must be differentiated primarily by their extraintestinal signs and affected genes.
4
Analyze the fourth vignette describing a moderate adenoma burden with negative family history.
An autosomal recessive pattern (healthy parents) with 10-100 adenomas indicates MUTYH-associated polyposis (MAP), which involves a defect in base excision repair.
MAP is the primary autosomal recessive polyposis syndrome and should be suspected when APC testing is negative.
5
Evaluate the fifth vignette highlighting macrocephaly and specific dermatological lesions.
Facial trichilemmomas, macrocephaly, hamartomas, and thyroid cancer describe Cowden syndrome, driven by a PTEN lipid phosphatase mutation.
PTEN normally regulates cell growth, and its loss leads to hamartoma formation across multiple tissue types.

Key Concept

Hereditary Polyposis and Colorectal Cancer Syndromes: Clinical Manifestations and Molecular Genetics
Question 420Question →

Evaluate the following clinical profiles of patients presenting with hypokalemia and acid-base disturbances. Match each patient's laboratory and clinical presentation with the most likely underlying pathophysiologic mechanism.

Click a left item, then click its matching right item

Items

A patient with refractory hypertension presents with profound muscle weakness. Laboratory evaluation reveals a serum potassium of 2.6 mEq/L, serum bicarbonate of 34 mEq/L, and a spot urine chloride of 52 mEq/L.
A normotensive young adult presents with chronic fatigue and denies taking any medications. Laboratory evaluation reveals a serum potassium of 2.4 mEq/L, serum bicarbonate of 36 mEq/L, and a spot urine chloride of 65 mEq/L.
A normotensive patient is evaluated for severe dental enamel erosions. Laboratory evaluation reveals a serum potassium of 2.5 mEq/L, serum bicarbonate of 38 mEq/L, and a spot urine chloride of 8 mEq/L.
A normotensive patient presents with recurrent calcium phosphate kidney stones. Laboratory evaluation reveals a serum potassium of 2.8 mEq/L, serum bicarbonate of 14 mEq/L, and a positive calculated urine anion gap.

Matches

Show answer & explanation

Answer

The hypertensive patient with high urine chloride has autonomous adrenal hypersecretion; the normotensive patient with high urine chloride has a tubular ion channel mutation; the normotensive patient with low urine chloride has surreptitious gastric fluid loss; and the patient with non-anion gap acidosis and positive urine anion gap has a distal tubular acidification defect.
Each clinical scenario corresponds to a distinct pathophysiologic node in the acid-base diagnostic algorithms. Saline-responsive alkalosis (low urine chloride) stems from gastric loss; saline-resistant alkalosis (high urine chloride) splits by blood pressure into mineralocorticoid excess (hypertension) or tubular defects (normotension). A non-anion gap acidosis with a positive urine anion gap points to an acidification defect (Type 1 RTA).

Step-by-Step Solution

1
Evaluate the pH and bicarbonate to determine the primary acid-base disorder.
Three patients have metabolic alkalosis (elevated bicarbonate), while one has a non-anion gap metabolic acidosis (decreased bicarbonate).
Categorizing the primary acid-base disorder dictates the subsequent diagnostic algorithm.
2
For the patients with metabolic alkalosis, analyze the spot urine chloride concentration.
One patient has low urine chloride (< 20 mEq/L), indicating a saline-responsive etiology (gastric loss). Two patients have high urine chloride (> 20 mEq/L), indicating saline-resistant etiologies.
Urine chloride differentiates volume-depleted states (where the kidney avidly reabsorbs chloride) from states of renal chloride wasting or volume expansion.
3
For the patients with high urine chloride metabolic alkalosis, evaluate the blood pressure.
The hypertensive patient has mineralocorticoid excess, while the normotensive patient has a tubular defect.
Mineralocorticoid excess causes sodium retention and hypertension, whereas tubular defects (like Gitelman syndrome) cause salt wasting and normotension/hypotension.
4
For the patient with non-anion gap metabolic acidosis, interpret the urine anion gap.
A positive urine anion gap indicates a renal cause of acidosis.
The positive gap signifies a failure of the kidneys to excrete ammonium (NH4+), which is characteristic of renal tubular acidosis (RTA).

Key Concept

The diagnostic algorithm for metabolic alkalosis relies heavily on spot urine chloride and blood pressure, while the urine anion gap helps diagnose renal tubular acidosis.
PreviousPage 21 / 158Next